WeVote
Log In

Bill

Bill

HB 1642

Regulating the sale of cannabis concentrates.

2023-2024 Regular Session Introduced by Lisa Callan and 11 co-sponsors

Washington bill establishes potency limits, packaging standards, and retail restrictions for cannabis concentrates to mitigate high-THC product risks.

By resolution, reintroduced and retained in present status.
0
WeVote Research Nonpartisan
Bill Summary · HB 1642

Legislative bill overview

HB 1642 proposes regulatory measures governing the sale and distribution of cannabis concentrates in Washington state. The bill would establish standards for product potency, packaging, labeling, and retail sales restrictions for concentrated cannabis products like oils, edibles, and extracts.

Why is this important

Cannabis concentrates contain significantly higher THC levels than flower, raising public health concerns about potency-related harms, particularly among youth and inexperienced users. Clear regulatory frameworks affect market competition, tax revenue, public health outcomes, and the legitimacy of Washington's existing legal cannabis industry.

Potential points of contention

  • Potency caps vs. market freedom: Limiting THC concentrations may conflict with adult consumer choice and cannabis retailer profits while supporters argue it protects public health.
  • Industry compliance costs: New packaging, testing, and labeling requirements could disproportionately burden small producers versus large operators with existing infrastructure.
  • Youth access prevention: Balancing effective age-restriction enforcement against practical retail operations and distinguishing legitimate regulation from de facto prohibition.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.